Mineralys outlines December 22 PDUFA timeline while funding lorundrostat launch into 2028
Earnings Call Insights: Mineralys Therapeutics (MLYS) Q3 2026
Management View
"We are now just weeks away from our PDUFA target date of December 22." (President, CEO & Director Jon Congleton)
"Our focus is on completing our launch preparations so that
Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.